The homeostasis model assessment of insulin resistance (HOMA-IR) is more commonly used due to its simplicity, but it relies on fasting insulin measurements, which may be inaccurate in individuals receiving insulin therapy or those with impaired β-cell function, and remains largely inaccessible in primary care settings in many regions (9). Here, INS is linked to Insulin resistance.